Rgenta Therapeutics
Brookline, MA
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.
rgentatx.comCompany Details
Founded
- 2018
Employees
- Between 20 - 50 employees
Raised
- $116,949,200
Headquarters Location
- Brookline, MA
Public
- No
Acquired
- No
CEO
Simon Xi
Founders
- Travis WagerSimon XiZhiping Weng
Company Collections
These are collections Rgenta Therapeutics is a part of. Click on the collection name to view similar companies.